Manulife (Manufacturers Life Insurance)’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.4M Buy
101,838
+39,760
+64% +$6.83M 0.02% 661
2026
Q1
$10.5M Buy
62,078
+4,533
+8% +$775K 0.01% 833
2025
Q4
$9.71M Buy
+57,545
New +$9.35M 0.01% 886
2018
Q3
– Sell
-1,323
Closed -$145K – 3371
2018
Q2
$145K Sell
1,323
-4,051
-75% -$433K ﹤0.01% 3313
2018
Q1
$574K Sell
5,374
-37,110
-87% -$4.11M ﹤0.01% 2235
2017
Q4
$4.54M Sell
42,484
-7,877
-16% -$842K ﹤0.01% 1248
2017
Q3
$5.6M Buy
50,361
+47,736
+1,819% +$5.1M 0.01% 1116
2017
Q2
$271K Buy
2,625
+15
+0.6% +$1.48K ﹤0.01% 2760
2017
Q1
$255K Sell
2,610
-22,518
-90% -$2.16M ﹤0.01% 2658
2016
Q4
$2.22M Buy
25,128
+22,359
+807% +$2.03M ﹤0.01% 1356
2016
Q3
$267K Sell
2,769
-264
-9% -$25.1K ﹤0.01% 2556
2016
Q2
$260K Buy
3,033
+1,251
+70% +$112K ﹤0.01% 2510
2016
Q1
$151K Buy
1,782
+606
+52% +$54.2K ﹤0.01% 2800
2015
Q4
$133K Sell
1,176
-12,903
-92% -$1.4M ﹤0.01% 2948
2015
Q3
$1.42M Buy
14,079
+14,016
+22,248% +$1.68M ﹤0.01% 1462
2015
Q2
$8K Sell
63
-10,800
-99% -$1.29M ﹤0.01% 3595
2015
Q1
$1.24M Buy
+10,863
New +$1.2M ﹤0.01% 1558
2014
Q3
– Sell
-294
Closed -$25K – 3970
2014
Q2
$25K Buy
+294
New +$23.2K ﹤0.01% 3323

Other funds holding IBB

Manulife (Manufacturers Life Insurance)'s IBB Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its iShares Biotechnology ETF (IBB) stake by 64% in Q2 2026, buying an estimated $6.83M and bringing the position to 101,838 shares worth $19.4M. The position accounts for 0.02% of the portfolio, ranked #661.

Manulife (Manufacturers Life Insurance) first reported a position in IBB in Q2 2014 and has held it in 18 quarters since. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 101,838 shares of iShares Biotechnology ETF worth $19.4M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) bought 39,760 iShares Biotechnology ETF shares in Q2 2026, an estimated $6.83M.
  • iShares Biotechnology ETF made up 0.02% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #661 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in iShares Biotechnology ETF in Q2 2014 and has held it in 18 quarters since.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.